drug,score,moa
gdsc_Alectinib,0.703,"ALK inhibitor, used to treat non-small-cell lung cancer (NSCLC)"
gdsc_Navitoclax,0.677,"Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and Bcl-w"
gdsc_GSK1070916,0.632,Not Clinically Relevant
gdsc_Linsitinib,0.626,IGF-1R inhibitor
gdsc_Quizartinib,0.624,Flt3 inhibitor
gdsc_Tubastatin A,0.608,Not Clinically Relevant
gdsc_SB52334,0.607,Not Clinically Relevant
gdsc_VX-702,0.607,Not Clinically Relevant
gdsc_TL-2-105,0.594,Not Clinically Relevant
gdsc_QL-XII-61,0.593,Not Clinically Relevant
gdsc_GSK429286A,0.583,Not Clinically Relevant
gdsc_Tretinoin,0.570,Retinoid
gdsc_BX-912,0.549,Not Clinically Relevant
gdsc_QL-XI-92,0.548,Not Clinically Relevant
gdsc_GW-2580,0.535,Not Clinically Relevant
gdsc_Rucaparib,0.528,"PARP inhibitor, inhibits DNA repair"
gdsc_Axitinib,0.522,"VEGFR, c-KIT and PDGFR inhibitor"
gdsc_Y-39983,0.516,Not Clinically Relevant
gdsc_Amuvatinib,0.495,Not Clinically Relevant
ctrp_linsitinib,0.484,IGF-1R inhibitor
ctrp_avrainvillamide,0.480,Not Clinically Relevant
gdsc_HG-5-88-01,0.472,Not Clinically Relevant
ctrp_tretinoin,0.470,Retinoid
gdsc_XMD14-99,0.470,Not Clinically Relevant
ctrp_barasertib,0.464,highly selective Aurora B kinase inhibitor
gdsc_XMD13-2,0.462,Not Clinically Relevant
gdsc_Ispinesib Mesylate,0.460,Not Clinically Relevant
ctrp_indisulam,0.459,"carbonic anhydrase inibitor and  CDK inhibitor, targets G1 by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2"
gdsc_GSK319347A,0.457,Not Clinically Relevant
ctrp_sotrastaurin,0.454,pan-PKC inhibitor
ctrp_staurosporine,0.451,Not Clinically Relevant
ctrp_tubastatin A,0.447,Not Clinically Relevant
gdsc_Masitinib,0.446,"tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs"
gdsc_SB-505124,0.439,Not Clinically Relevant
ctrp_CCT036477,0.437,Not Clinically Relevant
ctrp_ABT-737,0.435,Bcl-2/Bcl-xL inhibitor
ctrp_chlorambucil,0.433,"alkylates and cross-links DNA, interfering with DNA replication and damaging the DNA"
ctrp_BRD-K28456706,0.432,Not Clinically Relevant
ctrp_serdemetan,0.431,"(JNJ-26854165) Mdm2 antagonist, stabilizes p53"
ctrp_ML239,0.431,Not Clinically Relevant
ctrp_belinostat,0.429,HDAC inhibitor (PXD101)
ctrp_BRD-K26531177,0.428,Not Clinically Relevant
ctrp_BRD-A71883111,0.427,Not Clinically Relevant
ctrp_BMS-195614,0.424,Not Clinically Relevant
ctrp_PF-4800567 hydrochloride,0.422,Not Clinically Relevant
ctrp_olaparib,0.422,PARP Inhibitor
ctrp_IU1,0.420,Not Clinically Relevant
ctrp_skepinone-L,0.419,Not Clinically Relevant
ctrp_alisertib,0.419,Aurora A kinase inhibitor
ctrp_XL765,0.418,PI3K/mTOR inhibitor
ctrp_ML050,0.418,Not Clinically Relevant
ctrp_tacrolimus,0.415,"FK-506, immunosuppressive drug usedafter allogeneic organ transplant"
gdsc_Olaparib,0.415,PARP Inhibitor
ctrp_tipifarnib-P1,0.414,Not Clinically Relevant
ctrp_Compound 7d-cis,0.414,Not Clinically Relevant
ctrp_JW-74,0.414,Not Clinically Relevant
ctrp_BRD-K51490254,0.413,Not Clinically Relevant
ctrp_BRD-K42260513,0.409,Not Clinically Relevant
gdsc_Talazoparib,0.409,Not Clinically Relevant
ctrp_SR1001,0.406,Not Clinically Relevant
ctrp_BRD-K34485477,0.405,Not Clinically Relevant
ctrp_BRD-M00053801,0.405,Not Clinically Relevant
ctrp_KW-2449,0.405,"multi-kinase inhibitor, mostly for Flt3, modestly potent to FGFR1, Bcr-Abl and Aurora A;"
ctrp_epigallocatechin-3-monogallate,0.402,Not Clinically Relevant
ctrp_axitinib,0.402,"VEGFR, c-KIT and PDGFR inhibitor"
ctrp_tamoxifen,0.401,"ER antagonist prodrug; converted to 4-OHT and endoxifen in the liver; competes with estrogen for ER binding, inhibits transcription of estrogen target genes"
ctrp_CIL55,0.401,Not Clinically Relevant
ctrp_RG-108,0.400,Not Clinically Relevant
ctrp_BRD-K51831558,0.400,Not Clinically Relevant
ctrp_foretinib,0.399,c-Met/VEGFR2 inhibitor
ctrp_KPT185,0.397,Not Clinically Relevant
ctrp_BRD-K88742110,0.397,Not Clinically Relevant
ctrp_BRD-K13999467,0.396,Not Clinically Relevant
ctrp_BRD-K49290616,0.396,Not Clinically Relevant
ctrp_necrostatin-7,0.395,Not Clinically Relevant
ctrp_16-beta-bromoandrosterone,0.393,Not Clinically Relevant
ctrp_BRD-K29313308,0.391,Not Clinically Relevant
gdsc_NPK76-II-72-1,0.389,Not Clinically Relevant
gdsc_KIN001-266,0.388,Not Clinically Relevant
ctrp_PRIMA-1-Met,0.387,Not Clinically Relevant
ctrp_ML203,0.386,Not Clinically Relevant
ctrp_BMS-270394,0.386,Not Clinically Relevant
ctrp_NSC23766,0.384,Not Clinically Relevant
ctrp_Repligen 136,0.384,Not Clinically Relevant
ctrp_cytarabine hydrochloride,0.382,Not Clinically Relevant
ctrp_BIBR-1532,0.379,Not Clinically Relevant
ctrp_VX-680,0.379,"VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C"
ctrp_PX-12,0.379,thioredoxin-1 (Trx-1) inhibitor
ctrp_ceranib-2,0.379,Not Clinically Relevant
ctrp_AC55649,0.378,Not Clinically Relevant
ctrp_SB-431542,0.378,Not Clinically Relevant
ctrp_GMX-1778,0.377,Not Clinically Relevant
ctrp_LY-2183240,0.377,Not Clinically Relevant
gdsc_TPCA-1,0.377,Not Clinically Relevant
gdsc_BMS-536924,0.375,Not Clinically Relevant
ctrp_MST-312,0.374,Not Clinically Relevant
ctrp_SKI-II,0.374,Not Clinically Relevant
gdsc_Daporinad,0.374,"inhibits biosynthesis of (NAD+ from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells"
ctrp_elocalcitol,0.374,vitamin D receptor agonist
ctrp_BRD1835,0.372,Not Clinically Relevant
ctrp_NSC19630,0.372,Not Clinically Relevant
ctrp_isoliquiritigenin,0.370,Not Clinically Relevant
ctrp_NSC30930,0.370,Not Clinically Relevant
ctrp_itraconazole,0.369,"Anti-fungal, hedgehog antagonist"
ctrp_NSC 74859,0.368,Not Clinically Relevant
ctrp_BRD-K24690302,0.368,Not Clinically Relevant
ctrp_BMS-754807,0.368,Not Clinically Relevant
ctrp_Ki8751,0.368,Not Clinically Relevant
gdsc_BMS-345541,0.367,Not Clinically Relevant
ctrp_tacedinaline,0.367,Not Clinically Relevant
gdsc_Vorinostat,0.367,HDAC inhibitor (SAHA)
ctrp_ELCPK,0.366,Not Clinically Relevant
ctrp_BRD-K19103580,0.366,Not Clinically Relevant
gdsc_KIN001-270,0.366,Not Clinically Relevant
ctrp_fingolimod,0.366,"sphingosine-1-phosphate receptor modulator, sequesters lymphocytes in lymph nodes, mostly used for treating multiple sclerosis"
ctrp_SB-225002,0.365,Not Clinically Relevant
ctrp_Compound 1541A,0.365,Not Clinically Relevant
ctrp_PF-184,0.365,Not Clinically Relevant
ctrp_Mdivi-1,0.364,Not Clinically Relevant
ctrp_omacetaxine mepesuccinate,0.364,"natural product, protein translation inhibitor, used for myeloid leukemia"
ctrp_PDMP,0.364,Not Clinically Relevant
ctrp_ISOX,0.364,Not Clinically Relevant
ctrp_tivantinib,0.363,Met inhibitor
ctrp_BRD-K61166597,0.363,Not Clinically Relevant
ctrp_LRRK2-IN-1,0.363,Not Clinically Relevant
ctrp_SZ4TA2,0.363,Not Clinically Relevant
ctrp_lomeguatrib,0.362,"Inhibitor of MGMT, a DNA repair protein that confers resistance to alkylating agents such as Temozolomide, DTIC, Carmustine, etc. "
ctrp_apicidin,0.362,Not Clinically Relevant
ctrp_ruxolitinib,0.362,"JAK1/2 inhibitor, used for myelofibrosis and polycythemia vera"
ctrp_BIRB-796,0.361,Not Clinically Relevant
ctrp_BRD-K41597374,0.361,Not Clinically Relevant
ctrp_MGCD-265,0.361,"inhibitor of c-Met and VEGFR1/2/3, as well as Ron and Tie2"
ctrp_bexarotene,0.359,"retinoid that selectively activates retinoid X receptors (RXRs), induces cell differentiation and apoptosis "
ctrp_pandacostat,0.359,Not Clinically Relevant
ctrp_ML006,0.359,Not Clinically Relevant
ctrp_JW-55,0.359,Not Clinically Relevant
ctrp_BRD6340,0.359,Not Clinically Relevant
ctrp_CIL41,0.358,Not Clinically Relevant
gdsc_HG-5-113-01,0.357,Not Clinically Relevant
ctrp_AZD1480,0.356,JAK2 inhibitor with some activity against JAK3 and Tyk2
gdsc_Cisplatin,0.356,Not Clinically Relevant
ctrp_crizotinib,0.356,"ALK, ROS1 and MET inhibitor"
ctrp_vorinostat,0.356,HDAC inhibitor (SAHA)
gdsc_UNC1215,0.356,Not Clinically Relevant
ctrp_parbendazole,0.354,Not Clinically Relevant
ctrp_NVP-ADW742,0.354,Not Clinically Relevant
ctrp_topotecan,0.354,Topo I inhibitor
ctrp_isoevodiamine,0.354,Not Clinically Relevant
ctrp_ABT-199,0.353,Bcl2 inhibitor
ctrp_ML162,0.353,Not Clinically Relevant
ctrp_BRD-K11533227,0.352,Not Clinically Relevant
ctrp_sitagliptin,0.352,"used for Treating type 2 diabetes, works by increasing the amount of insulin released by your body"
ctrp_Compound 23 citrate,0.351,Not Clinically Relevant
ctrp_KU-55933,0.351,Not Clinically Relevant
ctrp_BRD-K90370028,0.351,Not Clinically Relevant
ctrp_HC-067047,0.350,Not Clinically Relevant
ctrp_lenvatinib,0.349,"VEGFR inhibitor (VEGFR1, VEGFR2 and VEGFR3)"
ctrp_BRD-K92856060,0.349,Not Clinically Relevant
ctrp_RITA,0.349,Not Clinically Relevant
ctrp_BRD-K02251932,0.349,Not Clinically Relevant
ctrp_GW-843682X,0.348,Not Clinically Relevant
ctrp_necrostatin-1,0.348,Not Clinically Relevant
ctrp_TG-100-115,0.347,PI3Kγ/δ inhibitor
ctrp_STF-31,0.346,Not Clinically Relevant
gdsc_AICA Ribonucleotide,0.346,Not Clinically Relevant
ctrp_NSC48300,0.346,Not Clinically Relevant
gdsc_PHA-793887,0.344,"CDK inhibitor, esp CDK2, CDK5 and CDK7"
ctrp_BRD-K80183349,0.344,Not Clinically Relevant
ctrp_pifithrin-mu,0.344,Not Clinically Relevant
ctrp_triazolothiadiazine,0.344,Not Clinically Relevant
ctrp_ibrutinib,0.341,BTK kinase inhibitor
ctrp_AM-580,0.341,Not Clinically Relevant
ctrp_BRD-K02492147,0.341,Not Clinically Relevant
ctrp_LBH-589,0.340,HDAC inhibitor
gdsc_SN-38,0.340,"Topo I inhibitor, active metabolite of irinotecan but 1000 times more active"
ctrp_L-685458,0.339,Not Clinically Relevant
ctrp_NSC95397,0.339,Not Clinically Relevant
ctrp_ML083,0.339,Not Clinically Relevant
ctrp_decitabine,0.338,"Nucleoside analog, inhibitor of DNA methylation and DNA synthesis (Dacogen)"
ctrp_ML311,0.338,Not Clinically Relevant
ctrp_cucurbitacin I,0.337,Not Clinically Relevant
ctrp_ML029,0.337,Not Clinically Relevant
ctrp_GSK1059615,0.337,PI3Kα/β/δ/γ and mTOR inhibitor
ctrp_PL-DI,0.336,Not Clinically Relevant
ctrp_nilotinib,0.336,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK"
ctrp_NVP-TAE684,0.336,Not Clinically Relevant
ctrp_hyperforin,0.336,"Active ingredient in St. John's Wort, blocks reuptake of of serotonin, norepinephrine, dopamine and GABA"
ctrp_trifluoperazine,0.336,"antipsychotic, antiadrenergic and antidopaminergic. Blocks dopamine D1 and D2 receptors "
ctrp_erastin,0.335,Not Clinically Relevant
ctrp_SN-38,0.335,"Topo I inhibitor, active metabolite of irinotecan but 1000 times more active"
ctrp_FQI-2,0.335,Not Clinically Relevant
ctrp_BRD-K66532283,0.335,Not Clinically Relevant
ctrp_CAY10576,0.335,Not Clinically Relevant
ctrp_BIX-01294,0.334,Not Clinically Relevant
ctrp_ETP-46464,0.334,Not Clinically Relevant
ctrp_BRD8899,0.334,Not Clinically Relevant
ctrp_BYL-719,0.333,PI3Kα inhibitor with minimal effect on PI3Kβ/γ/δ
ctrp_MI-1,0.333,Not Clinically Relevant
ctrp_sildenafil,0.333,"Viagra, used to treat erectile dysfunction and pulmonary arterial hypertension"
ctrp_AZD4547,0.333,"FGFR-1,2 and 3 inhibitor"
ctrp_GSK461364,0.333,"Plk1 inhibitor, less active against Plk2 and Plk3."
ctrp_AT-406,0.332,Not Clinically Relevant
ctrp_SGX-523,0.332, Met inhibitor
ctrp_PD 153035,0.331,Not Clinically Relevant
ctrp_RO4929097,0.331,Notch (gamma secretase) inhibitor
ctrp_HLI 373,0.331,Not Clinically Relevant
ctrp_BRD-K16147474,0.331,Not Clinically Relevant
ctrp_Merck60,0.330,Not Clinically Relevant
ctrp_PF-3758309,0.329,Not Clinically Relevant
ctrp_myriocin,0.329,Not Clinically Relevant
ctrp_BRD-K29086754,0.329,Not Clinically Relevant
gdsc_ZG-10,0.329,Not Clinically Relevant
ctrp_etoposide,0.329,Topo II inhibitor
ctrp_necrosulfonamide,0.329,Not Clinically Relevant
ctrp_istradefylline,0.328,"adenosine A2A receptor antagonist, useful in the treatment of Parkinson's disease"
ctrp_YK 4-279,0.327,Not Clinically Relevant
ctrp_FGIN-1-27,0.327,Not Clinically Relevant
ctrp_ML031,0.325,Not Clinically Relevant
ctrp_KX2-391,0.325,Src inhibitor (peptidomimetic) that targets the peptide substrate site of Src
ctrp_cabozantinib,0.325,"MET, AXL, VEGFR and RET inhibitor"
ctrp_vorapaxar,0.325," thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine"
ctrp_manumycin A,0.325,Not Clinically Relevant
gdsc_YM201636,0.324,Not Clinically Relevant
ctrp_fluorouracil,0.324,antimetabolite
ctrp_BI-2536,0.324,"Plk1 inhibitor, less active against Plk2 and Plk3."
ctrp_Ch-55,0.324,Not Clinically Relevant
ctrp_PI-103,0.323,Not Clinically Relevant
ctrp_brivanib,0.323,"multitargeted tyrosine kinase inhibitor, esp VEGFR and FGFR"
ctrp_nintedanib,0.323,"tyrosine-kinase inhibitor, targeting VEGFR, FGFR and PDGFR"
ctrp_bendamustine,0.323,alkylating agent
gdsc_MPS-1-IN-1,0.323,Not Clinically Relevant
ctrp_sorafenib,0.323,"VEGFR, PDGFR and Raf (c-Raf) inhibitor"
ctrp_pitstop2,0.322,Not Clinically Relevant
ctrp_PLX-4032,0.322,BRAF (V600E) inhibitor
ctrp_BMS-536924,0.321,Not Clinically Relevant
ctrp_mitomycin,0.321,"DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis"
ctrp_rigosertib,0.321,"ON-01910, Plk-1 inhibitor"
ctrp_ciclopirox,0.320,antifungal agent for topical dermatologic treatment of superficial mycoses
ctrp_BRD-K34222889,0.319,Not Clinically Relevant
ctrp_BRD-K70511574,0.319,Not Clinically Relevant
ctrp_neuronal differentiation inducer III,0.319,Not Clinically Relevant
ctrp_importazole,0.319,Not Clinically Relevant
ctrp_KU-0063794,0.318,Not Clinically Relevant
ctrp_BRD-K44224150,0.318,Not Clinically Relevant
ctrp_BRD-K04800985,0.318,Not Clinically Relevant
ctrp_cimetidine,0.318,(Tagamet) Antacid and antihistamine
ctrp_tamatinib,0.318,(R4060) inhibitor of IgE and IgG-mediated activation of Fc receptor signaling. Primary target is Syk
ctrp_SB-525334,0.318,Not Clinically Relevant
ctrp_N9-isopropylolomoucine,0.317,Not Clinically Relevant
ctrp_BRD-K84807411,0.316,Not Clinically Relevant
ctrp_SU11274,0.316,Not Clinically Relevant
ctrp_darinaparsin,0.316,organic arsenic compound composed of dimethylated arsenic linked to glutathione
ctrp_vincristine,0.316,"binds tubulin, disrupts microtubule dynamics"
ctrp_BRD-K35604418,0.315,Not Clinically Relevant
ctrp_NSC632839,0.315,Not Clinically Relevant
gdsc_BMS-754807,0.314,Not Clinically Relevant
ctrp_dacarbazine,0.314,"alkylating agent, Dacarbazine works by methylating guanine at the O-6 and N-7 positions"
gdsc_Methotrexate,0.314,"antimetabolite, competitively inhibits dihydrofolate reductase (DHFR), inhibits synthesis of DNA, RNA, thymidylates, and proteins"
ctrp_navitoclax,0.313,"Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and Bcl-w"
ctrp_cerulenin,0.313,Not Clinically Relevant
ctrp_CD-1530,0.312,Not Clinically Relevant
gdsc_ZM447439,0.311,Not Clinically Relevant
ctrp_UNC0638,0.311,Not Clinically Relevant
ctrp_968,0.311,Not Clinically Relevant
ctrp_CAY10618,0.311,Not Clinically Relevant
ctrp_NVP-BEZ235,0.311,PI3K/mTOR inhibitor
ctrp_pazopanib,0.311,"KIT, FGFR, PDGFR and VEGFR inhibitor"
ctrp_MK-2206,0.311,Akt1/2/3 inhibitor
ctrp_BRD1812,0.311,Not Clinically Relevant
ctrp_entinostat,0.310,HDAC inhibitor
ctrp_PYR-41,0.310,Not Clinically Relevant
ctrp_BRD-K66453893,0.310,Not Clinically Relevant
ctrp_teniposide,0.309,Topo II inhibitor
gdsc_I-BET-762,0.309,Not Clinically Relevant
gdsc_WZ3105,0.309,Not Clinically Relevant
ctrp_tivozanib,0.309,VEGFR inhibitor
ctrp_SMER-3,0.308,Not Clinically Relevant
ctrp_KH-CB19,0.308,Not Clinically Relevant
ctrp_narciclasine,0.308,Not Clinically Relevant
ctrp_nakiterpiosin,0.308,Not Clinically Relevant
gdsc_PIK-93,0.307,Not Clinically Relevant
ctrp_methylstat,0.307,Not Clinically Relevant
ctrp_Bax channel blocker,0.307,Not Clinically Relevant
ctrp_temozolomide,0.306,alkylating agent
ctrp_FQI-1,0.306,Not Clinically Relevant
ctrp_CHM-1,0.306,Not Clinically Relevant
gdsc_AR-42,0.306,Not Clinically Relevant
ctrp_BRD-K75293299,0.306,Not Clinically Relevant
ctrp_thalidomide,0.306,"interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma"
ctrp_OSI-027,0.305,Not Clinically Relevant
ctrp_cyclophosphamide,0.305,"alkylating agent, nitrogen mustard family, works by disrupting the duplication of DNA and the creation of RNA (Cytoxan)"
ctrp_pluripotin,0.305,Not Clinically Relevant
ctrp_BRD-K85133207,0.304,Not Clinically Relevant
ctrp_CIL70,0.304,Not Clinically Relevant
gdsc_AT-7519,0.304,Not Clinically Relevant
ctrp_NPC-26,0.304,Not Clinically Relevant
gdsc_5-Fluorouracil,0.304,antimetabolite
gdsc_CX-5461,0.303,Not Clinically Relevant
ctrp_gossypol,0.303,"Natural product, may function to inhibit Bcl2 family members"
ctrp_BRD-K37390332,0.303,Not Clinically Relevant
ctrp_JW-480,0.303,Not Clinically Relevant
ctrp_curcumin,0.303,"Natural Product, component of turmeric, may function as HDAC inhibitor"
ctrp_cediranib,0.302,VEGFR inhibitor
gdsc_Camptothecin,0.302,Not Clinically Relevant
ctrp_BRD-K86535717,0.302,Not Clinically Relevant
ctrp_MG-132,0.301,Not Clinically Relevant
ctrp_GSK-3 inhibitor IX,0.301,Not Clinically Relevant
ccle_PF2341066,0.301,"ALK, ROS1 and MET inhibitor"
ctrp_nutlin-3,0.300,"Mdm2 antagonist, stabilizes p53 "
ctrp_PF-573228,0.300,Not Clinically Relevant
ctrp_MI-2,0.300,Not Clinically Relevant
ctrp_doxorubicin,0.299,"Topo II inhibitor, DNA intercalator"
ctrp_PRIMA-1,0.299,Not Clinically Relevant
ctrp_leptomycin B,0.299,Not Clinically Relevant
gdsc_Fedratinib,0.299,JAK2 inhibitor
ctrp_B02,0.299,Not Clinically Relevant
ctrp_MK-1775,0.298,Wee1 kinase inhibitor
ctrp_silmitasertib,0.298,casein kinase 2 inhibitor 
ctrp_lapatinib,0.298,HER2/EGFR inhibitor
ctrp_AT13387,0.298,Selective potent Hsp90 inhibitor
ctrp_PIK-93,0.297,Not Clinically Relevant
ctrp_TPCA-1,0.296,Not Clinically Relevant
ctrp_linifanib,0.296,"RTK inhibitor, targets VEGFR, PDGFR, KDR, and CSF-1R"
ctrp_bardoxolone methyl,0.296,Not Clinically Relevant
ctrp_SCH-79797,0.296,Not Clinically Relevant
gdsc_CAY10603,0.295,Not Clinically Relevant
ctrp_AZ-3146,0.295,Not Clinically Relevant
ctrp_daporinad,0.295,"inhibits biosynthesis of (NAD+ from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells"
gdsc_NSC-207895,0.294,Not Clinically Relevant
ctrp_Ko-143,0.294,Not Clinically Relevant
ctrp_LY-2157299,0.294,Not Clinically Relevant
ctrp_WZ4002,0.294,Not Clinically Relevant
ctrp_NVP-231,0.293,Not Clinically Relevant
ctrp_BRD-A86708339,0.293,Not Clinically Relevant
gdsc_Belinostat,0.293,HDAC inhibitor (PXD101)
ctrp_VU0155056,0.292,Not Clinically Relevant
ctrp_tipifarnib-P2,0.292,Not Clinically Relevant
ctrp_paclitaxel,0.292,disrupts microtubule dynamics
ctrp_ZSTK474,0.291,"PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3Kδ"
ctrp_sunitinib,0.291,"VEGFR2, PDGFRb and c-kit inhibitor; also inhibits FLT3"
ctrp_BRD-K30019337,0.290,Not Clinically Relevant
ctrp_BRD-K96431673,0.290,Not Clinically Relevant
ctrp_AZD6482,0.289,"PI3Kβ inhibitor, less active against PI3Kδ, PI3Kα and PI3Kγ "
ctrp_CIL55A,0.288,Not Clinically Relevant
ctrp_semagacestat,0.288,Notch (gamma secretase) inhibitor
ctrp_tandutinib,0.288,"FLT3 antagonist, also inhibits PDGFR and c-Kit, "
ctrp_KU-60019,0.288,Not Clinically Relevant
gdsc_JW-7-24-1,0.288,Not Clinically Relevant
ctrp_TGX-221,0.288,Not Clinically Relevant
ctrp_PHA-793887,0.288,"CDK inhibitor, esp CDK2, CDK5 and CDK7"
ctrp_niclosamide,0.287,"used to treat tapeworm infestations,  inhibits glucose uptake, oxidative phosphorylation, and anaerobic metabolism in the tapeworm"
ctrp_salermide,0.287,Not Clinically Relevant
ctrp_SRT-1720,0.287,Not Clinically Relevant
ctrp_CD-437,0.287,Not Clinically Relevant
ctrp_phloretin,0.286,Not Clinically Relevant
gdsc_OSI-027,0.286,Not Clinically Relevant
ctrp_SCH-529074,0.286,Not Clinically Relevant
ctrp_OSI-930,0.286," inhibitor of Kit, KDR and CSF-1R; also potent to Flt-1, c-Raf and Lck"
ctrp_ouabain,0.286,Not Clinically Relevant
ctrp_AZD7762,0.285, Chk1 / Chk2 inhibitor
ctrp_GDC-0941,0.285,"Pictilisib, potent inhibitor of PI3Kα/δ, with modest selectivity against p110β (11-fold) and p110γ"
ctrp_pyrazolanthrone,0.285,Not Clinically Relevant
ctrp_cytochalasin B,0.285,Not Clinically Relevant
ctrp_GW-405833,0.284,Not Clinically Relevant
gdsc_Entinostat,0.283,HDAC inhibitor
ctrp_purmorphamine,0.283,Not Clinically Relevant
ctrp_temsirolimus,0.282,Not Clinically Relevant
ctrp_ML258,0.282,Not Clinically Relevant
ctrp_AGK-2,0.281,Not Clinically Relevant
ctrp_CAL-101,0.281,"Idelalisib,  PI3K/p110δ inhibitor"
ctrp_docetaxel,0.281,inhibits microtubule dynamics; semi-synthetic analogue of paclitaxel
ctrp_BRD-K45681478,0.280,Not Clinically Relevant
ctrp_palmostatin B,0.280,Not Clinically Relevant
ctrp_C6-ceramide,0.280,Not Clinically Relevant
ctrp_triptolide,0.279,"diterpenoid epoxide from thunder god vine, may act on the XBP helicase that is a part of the TFIIH transcription factor complex"
ctrp_SR-II-138A,0.279,Not Clinically Relevant
ctrp_pifithrin-alpha,0.279,Not Clinically Relevant
ctrp_QS-11,0.278,Not Clinically Relevant
ctrp_simvastatin,0.278,"HMG-CoA reductase inhibitor,"
ctrp_quizartinib,0.278,Flt3 inhibitor
ctrp_PF-750,0.278,Not Clinically Relevant
gdsc_QL-X-138,0.278,Not Clinically Relevant
ctrp_SB-743921,0.278,kinesin spindle protein (KSP) inhibitor
ctrp_veliparib,0.277,PARP inhibitor.
ctrp_CR-1-31B,0.277,Not Clinically Relevant
ctrp_fluvastatin,0.277,"HMG-CoA reductase inhibitor,"
ctrp_BRD-K78574327,0.276,Not Clinically Relevant
ctrp_GANT-61,0.276,Not Clinically Relevant
ctrp_parthenolide,0.276,Not Clinically Relevant
ctrp_BRD-A94377914,0.276,Not Clinically Relevant
ctrp_BRD-A05715709,0.275,Not Clinically Relevant
gdsc_WIKI4,0.274,Not Clinically Relevant
ctrp_HBX-41108,0.274,Not Clinically Relevant
ctrp_I-BET151,0.274,Not Clinically Relevant
ctrp_ciclosporin,0.273,
ctrp_piperlongumine,0.273,Not Clinically Relevant
ctrp_bleomycin A2,0.273,"Induces DNA strand breaks, inhibits incorporation of thymidine into DNA strands."
gdsc_CUDC-101,0.273,Not Clinically Relevant
ctrp_JQ-1,0.272,Not Clinically Relevant
ctrp_MK-0752,0.272,Notch (gamma secretase) inhibitor
ctrp_marinopyrrole A,0.272,Not Clinically Relevant
ctrp_PRL-3 inhibitor I,0.272,Not Clinically Relevant
ctrp_3-Cl-AHPC,0.272,Not Clinically Relevant
ctrp_momelotinib,0.272,JAK1 and JAK2 inhibitor
ctrp_clofarabine,0.271,purine nucleoside antimetabolite
ctrp_GSK2636771,0.270,"PI3K beta inhibitor, >900-fold selectivity over PI3Kα/PI3Kγ and >10-fold over PI3Kδ. "
ctrp_NVP-BSK805,0.270,Not Clinically Relevant
gdsc_UNC0638,0.269,Not Clinically Relevant
gdsc_CP466722,0.268,Not Clinically Relevant
gdsc_BX796,0.267,Not Clinically Relevant
gdsc_Genentech Cpd 10,0.267,Not Clinically Relevant
ctrp_AT7867,0.267,Not Clinically Relevant
ctrp_R428,0.265,Not Clinically Relevant
ctrp_CIL56,0.265,Not Clinically Relevant
ctrp_blebbistatin,0.265,Not Clinically Relevant
ctrp_BMS-345541,0.265,Not Clinically Relevant
ctrp_MLN2480,0.265,"TAK-580, pan-Raf kinase inhibitor"
ctrp_PAC-1,0.265,Not Clinically Relevant
ctrp_BRD-K41334119,0.263,Not Clinically Relevant
ctrp_BRD-K96970199,0.263,Not Clinically Relevant
ctrp_gemcitabine,0.262,"Nucleoside analog,incorporation into DNA creates an irreparable error that leads to inhibition of further DNA synthesis"
ctrp_RAF265,0.262,inhibitor of C-Raf/B-Raf/B-Raf V600E
ctrp_UNC0321,0.262,Not Clinically Relevant
ctrp_tosedostat,0.261,inhibitor of the M1 family of aminopeptidases
ctrp_ML312,0.261,Not Clinically Relevant
ctrp_sirolimus,0.261,"rapamycin, mTOR inhibitor"
ctrp_pevonedistat,0.261,"(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)"
ctrp_WZ8040,0.261,Not Clinically Relevant
ctrp_GSK525762A,0.260,Not Clinically Relevant
ctrp_myricetin,0.260,Not Clinically Relevant
ccle_AEW541,0.260,Not Clinically Relevant
ctrp_CHIR-99021,0.260,Not Clinically Relevant
ctrp_cyanoquinoline 11,0.260,Not Clinically Relevant
ctrp_alvocidib,0.260,"Flavopiridol, CDK inhibitor, works against CDK1, 2, 4, 6 and 9"
ctrp_prochlorperazine,0.259,"dopamine (D2) receptor antagonist, used for treatment of nausea and vertigo."
ctrp_ML210,0.258,Not Clinically Relevant
ctrp_dexamethasone,0.258,"synthetic corticosteroid, used to reduce inflammation"
ctrp_masitinib,0.258,"tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs"
ctrp_dinaciclib,0.257,"CDK inhibitor, esp CDK1, 2, 5, and 9"
ctrp_LE-135,0.257,Not Clinically Relevant
ctrp_BRD-K34099515,0.257,Not Clinically Relevant
ctrp_regorafenib,0.257,VEGFR2-TIE2 inhibitor 
ctrp_TW-37,0.256,Not Clinically Relevant
gdsc_GSK690693,0.255,Not Clinically Relevant
ctrp_canertinib,0.255,"pan-ErbB inhibitor for EGFR and ErbB2,  no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4. "
ccle_Irinotecan,0.254,"aka CPT-11, inhibitor of Topo I"
ctrp_QW-BI-011,0.253,Not Clinically Relevant
ctrp_obatoclax,0.253,Not Clinically Relevant
ctrp_YM-155,0.252,"YM155 (Sepantronium Bromide), survivin suppressant "
ctrp_DBeQ,0.252,Not Clinically Relevant
ctrp_BRD-A02303741,0.252,Not Clinically Relevant
gdsc_Mitomycin-C,0.252,"DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis"
ctrp_WP1130,0.251,Not Clinically Relevant
gdsc_Etoposide,0.251,Topo II inhibitor
ctrp_BRD9876,0.251,Not Clinically Relevant
ctrp_CI-976,0.250,Not Clinically Relevant
ctrp_ML320,0.249,Not Clinically Relevant
gdsc_Sepantronium bromide,0.249,"YM155 (Sepantronium Bromide), survivin suppressant "
ctrp_BRD-K01737880,0.247,Not Clinically Relevant
ctrp_AZD8055,0.247,mTOR inhibitor
ctrp_tigecycline,0.246,antibiotic used to treat a number of bacterial infections
gdsc_QL-XII-47,0.246,Not Clinically Relevant
ctrp_SNX-2112,0.246,Not Clinically Relevant
gdsc_TW 37,0.246,Not Clinically Relevant
gdsc_Dacinostat,0.246,Not Clinically Relevant
ccle_TAE684,0.245,Not Clinically Relevant
ctrp_EX-527,0.244,SIRT1 inhibitor
ctrp_SID 26681509,0.242,Not Clinically Relevant
ctrp_GSK-J4,0.241,Not Clinically Relevant
ctrp_SR8278,0.238,Not Clinically Relevant
ctrp_oligomycin A,0.237,Not Clinically Relevant
ctrp_TG-101348,0.237,JAK2 inhibitor
gdsc_PI-103,0.236,Not Clinically Relevant
ctrp_StemRegenin 1,0.236,Not Clinically Relevant
"ctrp_1S,3R-RSL-3",0.235,Not Clinically Relevant
ctrp_KU 0060648,0.232,Not Clinically Relevant
gdsc_THZ-2-102-1,0.231,Not Clinically Relevant
ctrp_BRD-K30748066,0.228,Not Clinically Relevant
ctrp_BRD4132,0.228,Not Clinically Relevant
ctrp_fulvestrant,0.226,selective estrogen receptor degrader (SERD)
ctrp_lovastatin,0.221,"HMG-CoA reductase inhibitor,"
ctrp_vandetanib,0.220,"VEGFR, EGFR and RET inhibitor"
ctrp_SNS-032,0.215,"CDK inhibitor, esp CDK2 , 7 and 9 "
ctrp_neopeltolide,0.214,Not Clinically Relevant
ctrp_BRD-K33514849,0.203,Not Clinically Relevant
ccle_Topotecan,0.197,Topo I inhibitor
ccle_Paclitaxel,0.185,disrupts microtubule dynamics
ctrp_bafilomycin A1,-0.185,Not Clinically Relevant
ctrp_methotrexate,-0.189,"antimetabolite, competitively inhibits dihydrofolate reductase (DHFR), inhibits synthesis of DNA, RNA, thymidylates, and proteins"
ctrp_BEC,-0.190,Not Clinically Relevant
ccle_RAF265,-0.207,inhibitor of C-Raf/B-Raf/B-Raf V600E
ctrp_BRD-K71935468,-0.215,Not Clinically Relevant
ccle_17-AAG,-0.217,Not Clinically Relevant
gdsc_Nilotinib,-0.219,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK"
gdsc_IPA-3,-0.226,Not Clinically Relevant
gdsc_TL-1-85,-0.227,Not Clinically Relevant
gdsc_NG-25,-0.228,Not Clinically Relevant
ccle_AZD0530,-0.232,"kinase inhibitor, with selectivity against Src and Bcr-Abl"
ctrp_neratinib,-0.233,Her2 and EGFR inhibitor
ctrp_tanespimycin,-0.234,HSP90 inhibitor
ctrp_austocystin D,-0.235,Not Clinically Relevant
ctrp_KHS101,-0.236,Not Clinically Relevant
ctrp_brefeldin A,-0.242,Not Clinically Relevant
ccle_TKI258,-0.247,Not Clinically Relevant
ctrp_BRD8958,-0.247,Not Clinically Relevant
ctrp_saracatinib,-0.248,"kinase inhibitor, with selectivity against Src and Bcr-Abl"
ctrp_BRD-K63431240,-0.248,Not Clinically Relevant
ctrp_avicin D,-0.249,Not Clinically Relevant
ctrp_COL-3,-0.249,matrix metalloproteinase (MMP) inhibitor
ctrp_betulinic acid,-0.250,Not Clinically Relevant
ctrp_BRD-K48334597,-0.251,Not Clinically Relevant
gdsc_DMOG,-0.252,Not Clinically Relevant
ctrp_valdecoxib,-0.252,"NSAID used in the treatment of osteoarthritis, rheumatoid arthritis"
gdsc_Gemcitabine,-0.253,"Nucleoside analog,incorporation into DNA creates an irreparable error that leads to inhibition of further DNA synthesis"
gdsc_Phenformin,-0.254,Anti-diabetic AMPK Activator - mTOR Inhibitor - Autophagy inducer
gdsc_Doxorubicin,-0.255,"Topo II inhibitor, DNA intercalator"
ctrp_gefitinib,-0.255,EGFR inhibitor (Iressa)
gdsc_SNX-2112,-0.255,Not Clinically Relevant
ctrp_BRD-K27224038,-0.256,Not Clinically Relevant
ctrp_bosutinib,-0.259,"BCR-Abl, Src, Lyn and Hck inhibitor"
gdsc_Epothilone B,-0.259,Not Clinically Relevant
ctrp_selumetinib,-0.261,MEK1 inhibitor
ctrp_CAY10594,-0.261,Not Clinically Relevant
ccle_PD-0325901,-0.263,Not Clinically Relevant
gdsc_GSK650394,-0.264,Not Clinically Relevant
ccle_L-685458,-0.264,Not Clinically Relevant
ccle_ZD-6474,-0.266,"VEGFR, EGFR and RET inhibitor"
ctrp_abiraterone,-0.266,steroidal CYP17A1 inhibitor and androgen synthesis inhibitor 
ctrp_BRD-K14844214,-0.266,Not Clinically Relevant
ctrp_BRD-K55116708,-0.268,Not Clinically Relevant
ctrp_AZD7545,-0.268,Not Clinically Relevant
ctrp_spautin-1,-0.269,Not Clinically Relevant
ctrp_BRD-K97651142,-0.270,Not Clinically Relevant
ccle_Sorafenib,-0.270,"VEGFR, PDGFR and Raf (c-Raf) inhibitor"
gdsc_Vinblastine,-0.271,"disrupts microtubule dynamics; vinca alkaloid, chemical analogue of vincristine"
ctrp_BRD-K48477130,-0.271,Not Clinically Relevant
gdsc_THZ-2-49,-0.271,Not Clinically Relevant
gdsc_Imatinib,-0.273,"Bcr-abl, c-kit and PDGFR inhibitor"
gdsc_JQ1,-0.274,Not Clinically Relevant
ctrp_ifosfamide,-0.277,"alkylating agent, nitrogen mustard family, works by disrupting the duplication of DNA and the creation of RNA"
ctrp_VER-155008,-0.277,Not Clinically Relevant
ccle_Lapatinib,-0.278,HER2/EGFR inhibitor
gdsc_Lestauritinib,-0.278,Not Clinically Relevant
ccle_PD-0332991,-0.278,CDK4/6 inhibitor
ctrp_CID-5951923,-0.278,Not Clinically Relevant
ctrp_bortezomib,-0.280,proteasome inhibitor (Velcade)
ctrp_BRD-K27986637,-0.280,Not Clinically Relevant
gdsc_AZD7762,-0.280, Chk1 / Chk2 inhibitor
gdsc_BAY-61-3606,-0.280,Not Clinically Relevant
gdsc_Elesclomol,-0.280,Not Clinically Relevant
gdsc_SB590885,-0.281,Not Clinically Relevant
gdsc_Vinorelbine,-0.281,Not Clinically Relevant
ctrp_BRD-K09344309,-0.285,Not Clinically Relevant
gdsc_YK-4-279,-0.287,Not Clinically Relevant
ctrp_nelarabine,-0.288,"purine nucleoside analog, which causes inhibition of DNA synthesis and cytotoxicity"
gdsc_AS605240,-0.288,Not Clinically Relevant
ctrp_WAY-362450,-0.288,Not Clinically Relevant
ctrp_SJ-172550,-0.289,Not Clinically Relevant
ctrp_ML334 diastereomer,-0.289,Not Clinically Relevant
ctrp_MLN2238,-0.290,"Ixazomib, Proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome "
gdsc_OSU-03012,-0.291,Not Clinically Relevant
ctrp_A-804598,-0.293,Not Clinically Relevant
gdsc_GW843682X,-0.294,Not Clinically Relevant
gdsc_Cytarabine,-0.295,"antimetabolite, causes DNA damage,  inhibits both DNA and RNA polymerases and nucleotide reductase enzymes needed for DNA synthesis"
gdsc_BI-2536,-0.297,"Plk1 inhibitor, less active against Plk2 and Plk3."
gdsc_CCT-018159,-0.297,Not Clinically Relevant
ctrp_fumonisin B1,-0.298,Not Clinically Relevant
ctrp_BRD-K94991378,-0.301,Not Clinically Relevant
gdsc_JQ12,-0.301,Not Clinically Relevant
gdsc_PFI-1,-0.302,Not Clinically Relevant
gdsc_KIN001-244,-0.303,Not Clinically Relevant
gdsc_Shikonin,-0.303,Not Clinically Relevant
gdsc_Docetaxel,-0.304,inhibits microtubule dynamics; semi-synthetic analogue of paclitaxel
ctrp_PD318088,-0.304,Not Clinically Relevant
gdsc_Omipalisib,-0.305,Not Clinically Relevant
ctrp_dasatinib,-0.307,"BCR-Abl, Src, c-Kit inhibitor"
ccle_PHA-665752,-0.308,Not Clinically Relevant
ccle_PLX4720,-0.308,Not Clinically Relevant
ctrp_VAF-347,-0.308,Not Clinically Relevant
gdsc_Palbociclib,-0.309,CDK4/6 inhibitor
ctrp_GDC-0879,-0.309,Not Clinically Relevant
ccle_Panobinostat,-0.310,HDAC inhibitor
gdsc_XMD8-92,-0.310,Not Clinically Relevant
gdsc_Pictilisib,-0.310,"Pictilisib, potent inhibitor of PI3Kα/δ, with modest selectivity against p110β (11-fold) and p110γ"
ctrp_AA-COCF3,-0.310,Not Clinically Relevant
gdsc_Embelin,-0.311,Not Clinically Relevant
ctrp_afatinib,-0.311,EGFR and ErbB2 inhibitor
gdsc_CMK,-0.312,Not Clinically Relevant
ctrp_BRD-K17060750,-0.313,Not Clinically Relevant
ccle_Erlotinib,-0.314,EGFR inhibitor (Tarceva)
gdsc_Erlotinib,-0.314,EGFR inhibitor (Tarceva)
ccle_Nutlin-3,-0.315,"Mdm2 antagonist, stabilizes p53 "
gdsc_ZSTK474,-0.317,"PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3Kδ"
ctrp_trametinib,-0.317,MEK inhibitor (MEK1 and MEK2)
ctrp_erismodegib,-0.318,Hedgehog (Smoothened) antagonist (LDE225)
ctrp_BRD-K50799972,-0.318,Not Clinically Relevant
gdsc_Seliciclib,-0.319,Not Clinically Relevant
ctrp_azacitidine,-0.319,"Nucleoside analog, inhibitor of DNA methylation and DNA/RNA synthesis (Vidaza)"
ctrp_FSC231,-0.320,Not Clinically Relevant
gdsc_AZD8055,-0.320,mTOR inhibitor
ctrp_GSK4112,-0.321,Not Clinically Relevant
gdsc_PF-562271,-0.321,Not Clinically Relevant
gdsc_Lapatinib,-0.323,HER2/EGFR inhibitor
gdsc_Ponatinib,-0.323,Bcr-abl inhibitor
ctrp_PF-543,-0.324,Not Clinically Relevant
ccle_AZD6244,-0.324,MEK1 inhibitor
ctrp_BRD-K71781559,-0.324,Not Clinically Relevant
gdsc_S-Trityl-L-cysteine,-0.325,Not Clinically Relevant
gdsc_Thapsigargin,-0.325,Not Clinically Relevant
ctrp_BRD-K64610608,-0.325,Not Clinically Relevant
gdsc_Serdemetan,-0.327,"(JNJ-26854165) Mdm2 antagonist, stabilizes p53"
gdsc_A-443654,-0.329,Not Clinically Relevant
gdsc_Luminespib,-0.329,Not Clinically Relevant
gdsc_Obatoclax Mesylate,-0.334,Not Clinically Relevant
ctrp_BRD-K09587429,-0.334,Not Clinically Relevant
ctrp_BCL-LZH-4,-0.335,Not Clinically Relevant
ccle_LBW242,-0.335,Not Clinically Relevant
gdsc_Saracatinib,-0.335,"kinase inhibitor, with selectivity against Src and Bcr-Abl"
ctrp_BRD-K33199242,-0.337,Not Clinically Relevant
ctrp_IPR-456,-0.338,Not Clinically Relevant
ctrp_CBB-1007,-0.338,Not Clinically Relevant
gdsc_Enzastaurin,-0.341,Not Clinically Relevant
gdsc_Zibotentan,-0.342,Not Clinically Relevant
ctrp_procarbazine,-0.342,alkylating agent
ccle_Nilotinib,-0.342,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK"
gdsc_Bleomycin,-0.343,"Induces DNA strand breaks, inhibits incorporation of thymidine into DNA strands."
ctrp_BRD9647,-0.344,Not Clinically Relevant
gdsc_Midostaurin,-0.344,Not Clinically Relevant
gdsc_MK-2206,-0.345,Akt1/2/3 inhibitor
gdsc_Bicalutamide,-0.346,"antiandrogen, used to treat prostate cancer"
gdsc_Pyrimethamine,-0.347,Not Clinically Relevant
gdsc_Paclitaxel,-0.347,disrupts microtubule dynamics
gdsc_GSK269962A,-0.348,Not Clinically Relevant
gdsc_JNK-9L,-0.349,Not Clinically Relevant
gdsc_Dactolisib,-0.350,PI3K/mTOR inhibitor
gdsc_PD0325901,-0.351,Not Clinically Relevant
gdsc_Tipifarnib,-0.353,Not Clinically Relevant
gdsc_Bleomycin (50 uM),-0.353,Not Clinically Relevant
ctrp_BRD-K52037352,-0.356,Not Clinically Relevant
gdsc_(5Z)-7-Oxozeaenol,-0.357,Not Clinically Relevant
gdsc_Salubrinal,-0.357,Not Clinically Relevant
gdsc_NVP-BHG712,-0.359,Not Clinically Relevant
gdsc_AKT inhibitor VIII,-0.360,Not Clinically Relevant
gdsc_Piperlongumine,-0.360,Not Clinically Relevant
ctrp_etomoxir,-0.363,"agonist of PPARα, inhibitor of carnitine palmitoyltransferase-1 (CPT-1)"
gdsc_OSI-930,-0.364," inhibitor of Kit, KDR and CSF-1R; also potent to Flt-1, c-Raf and Lck"
ctrp_zebularine,-0.366,Not Clinically Relevant
gdsc_SGC0946,-0.366,Not Clinically Relevant
gdsc_QL-VIII-58,-0.367,Not Clinically Relevant
ctrp_isonicotinohydroxamic acid,-0.368,Not Clinically Relevant
gdsc_AS601245,-0.370,Not Clinically Relevant
gdsc_Avagacestat,-0.371,Not Clinically Relevant
ctrp_IC-87114,-0.371,Not Clinically Relevant
gdsc_HG6-64-1,-0.372,Not Clinically Relevant
ctrp_imatinib,-0.374,"Bcr-abl, c-kit and PDGFR inhibitor"
gdsc_WH-4-023,-0.375,Not Clinically Relevant
gdsc_LFM-A13,-0.376,Not Clinically Relevant
gdsc_Tamoxifen,-0.379,"ER antagonist prodrug; converted to 4-OHT and endoxifen in the liver; competes with estrogen for ER binding, inhibits transcription of estrogen target genes"
ctrp_BRD-K99006945,-0.380,Not Clinically Relevant
gdsc_FH535,-0.381,Not Clinically Relevant
gdsc_SL0101,-0.384,Not Clinically Relevant
gdsc_Pevonedistat,-0.388,"(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)"
gdsc_XMD11-85h,-0.390,Not Clinically Relevant
gdsc_PF-4708671,-0.392,Not Clinically Relevant
gdsc_Trametinib,-0.393,MEK inhibitor (MEK1 and MEK2)
gdsc_Refametinib,-0.394,Not Clinically Relevant
gdsc_MG-132,-0.394,Not Clinically Relevant
ctrp_erlotinib,-0.395,EGFR inhibitor (Tarceva)
gdsc_STF-62247,-0.398,Not Clinically Relevant
gdsc_Sunitinib,-0.398,"VEGFR2, PDGFRb and c-kit inhibitor; also inhibits FLT3"
gdsc_XMD8-85,-0.399,Not Clinically Relevant
gdsc_FR-180204,-0.400,Not Clinically Relevant
gdsc_KIN001-236,-0.400,Not Clinically Relevant
ctrp_birinapant,-0.403,"SMAC mimetic, mostly to cIAP1, less potent against XIAP."
gdsc_Temsirolimus,-0.403,Not Clinically Relevant
ctrp_compound 1B,-0.403,Not Clinically Relevant
gdsc_CCT007093,-0.404,Not Clinically Relevant
gdsc_TGX221,-0.405,Not Clinically Relevant
gdsc_XMD15-27,-0.406,Not Clinically Relevant
gdsc_FTI-277,-0.408,Not Clinically Relevant
gdsc_A-770041,-0.409,Not Clinically Relevant
ctrp_PLX-4720,-0.409,Not Clinically Relevant
gdsc_BMS-509744,-0.416,Not Clinically Relevant
gdsc_GSK1904529A,-0.416,Not Clinically Relevant
gdsc_JW-7-52-1,-0.417,Not Clinically Relevant
gdsc_Doramapimod,-0.419,Not Clinically Relevant
gdsc_FMK,-0.419,Not Clinically Relevant
gdsc_CHIR-99021,-0.419,Not Clinically Relevant
gdsc_NVP-TAE684,-0.419,Not Clinically Relevant
gdsc_JNK Inhibitor VIII,-0.421,Not Clinically Relevant
gdsc_Dasatinib,-0.421,"BCR-Abl, Src, c-Kit inhibitor"
gdsc_CI-1040,-0.421,Not Clinically Relevant
gdsc_Temozolomide,-0.421,alkylating agent
gdsc_Lenalidomide,-0.422,"derivative of thalidomide, which interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma"
ctrp_O-6-benzylguanine,-0.424,"guanine analog, binds the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) resulting in inhibition of AGT-mediated DNA repair"
gdsc_Selisistat,-0.425,SIRT1 inhibitor
gdsc_NU7441,-0.425,Not Clinically Relevant
gdsc_KU-55933,-0.426,Not Clinically Relevant
gdsc_Cabozantinib,-0.431,"MET, AXL, VEGFR and RET inhibitor"
gdsc_EHT-1864,-0.433,Not Clinically Relevant
gdsc_TAK-715,-0.435,Not Clinically Relevant
gdsc_Veliparib,-0.436,PARP inhibitor.
gdsc_CGP-60474,-0.436,Not Clinically Relevant
gdsc_Bortezomib,-0.438,proteasome inhibitor (Velcade)
gdsc_Z-LLNle-CHO,-0.439,Not Clinically Relevant
gdsc_CGP-082996,-0.439,Not Clinically Relevant
gdsc_WHI-P97,-0.439,Not Clinically Relevant
gdsc_Vismodegib,-0.445,Hedgehog (Smoothened) antagonist (GDC-0449)
gdsc_BIX02189,-0.447,Not Clinically Relevant
gdsc_Bexarotene,-0.455,"retinoid that selectively activates retinoid X receptors (RXRs), induces cell differentiation and apoptosis "
gdsc_RO-3306,-0.456,Not Clinically Relevant
gdsc_CP724714,-0.456,Not Clinically Relevant
gdsc_XAV939,-0.457,Not Clinically Relevant
gdsc_IOX2,-0.459,Not Clinically Relevant
gdsc_NSC-87877,-0.460,Not Clinically Relevant
gdsc_SB216763,-0.463,Not Clinically Relevant
gdsc_Bryostatin 1,-0.464,Not Clinically Relevant
ctrp_dabrafenib,-0.467,Braf (V600E) inhibitor
gdsc_Tanespimycin,-0.472,HSP90 inhibitor
gdsc_PAC-1,-0.473,Not Clinically Relevant
gdsc_Motesanib,-0.476,Not Clinically Relevant
gdsc_AZD6482,-0.478,"PI3Kβ inhibitor, less active against PI3Kδ, PI3Kα and PI3Kγ "
gdsc_Tozasertib,-0.483,"VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C"
gdsc_Tivozanib,-0.487,VEGFR inhibitor
gdsc_Idelalisib,-0.488,"Idelalisib,  PI3K/p110δ inhibitor"
gdsc_PLX-4720,-0.493,Not Clinically Relevant
gdsc_Pelitinib,-0.494,Not Clinically Relevant
gdsc_Bosutinib,-0.494,"BCR-Abl, Src, Lyn and Hck inhibitor"
gdsc_Pazopanib,-0.495,"KIT, FGFR, PDGFR and VEGFR inhibitor"
gdsc_681640,-0.500,Not Clinically Relevant
gdsc_Rapamycin,-0.503,"rapamycin, mTOR inhibitor"
gdsc_Sorafenib,-0.506,"VEGFR, PDGFR and Raf (c-Raf) inhibitor"
gdsc_KIN001-260,-0.513,Not Clinically Relevant
gdsc_Gefitinib,-0.514,EGFR inhibitor (Iressa)
gdsc_Parthenolide,-0.525,Not Clinically Relevant
gdsc_PD173074,-0.538,Not Clinically Relevant
gdsc_AZ628,-0.540,Not Clinically Relevant
gdsc_QS11,-0.546,Not Clinically Relevant
gdsc_rTRAIL,-0.549,Not Clinically Relevant
gdsc_T0901317,-0.551,Not Clinically Relevant
gdsc_WZ-1-84,-0.563,Not Clinically Relevant
gdsc_Afatinib,-0.564,EGFR and ErbB2 inhibitor
gdsc_Cetuximab,-0.572,Not Clinically Relevant
gdsc_Selumetinib,-0.576,MEK1 inhibitor
gdsc_Crizotinib,-0.578,"ALK, ROS1 and MET inhibitor"
gdsc_Dabrafenib,-0.584,Braf (V600E) inhibitor
gdsc_Cyclopamine,-0.585,Not Clinically Relevant
gdsc_GNF-2,-0.590,Not Clinically Relevant
gdsc_VX-11e,-0.593,Not Clinically Relevant
gdsc_Nutlin-3a (-),-0.595,Not Clinically Relevant
gdsc_PHA-665752,-0.599,Not Clinically Relevant
gdsc_GW441756,-0.600,Not Clinically Relevant
gdsc_Linifanib,-0.603,"RTK inhibitor, targets VEGFR, PDGFR, KDR, and CSF-1R"
gdsc_VNLG/124,-0.685,Not Clinically Relevant
gdsc_Ruxolitinib,-0.710,"JAK1/2 inhibitor, used for myelofibrosis and polycythemia vera"
